Wash U Investigators Infer Putative Metastasis Suppressor in Uveal Melanomas | GenomeWeb

Uveal melanoma, though rare in general, is the most common form of eye cancer — and a highly aggressive one at that. About half of all uveal melanomas that arise metastasize, at which point they're identified as class 2 tumors. Because approximately 90 percent of class 2 tumors — for which there is no treatment and the average patient's life expectancy is less than a year — are associated with monosomy at chromosome 3, the Washington University in St. Louis School of Medicine's Anne Bowcock and her colleagues sought to sequence candidate genes specific to class 2 uveal melanomas there.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.